Tao Yuan, Taiwan

Ye-Lin Leu

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ye-Lin Leu. Retrieved from https://idiyas.com/inventor/ye-lin-leu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:

goldMedal1 out of 834,708 
Other
 patents

Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ye-Lin Leu: Innovator in Antitumor Compounds

Introduction

Ye-Lin Leu is a notable inventor based in Tao Yuan, Taiwan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of proactive antitumor compounds. Her innovative work has the potential to impact cancer treatment and improve patient outcomes.

Latest Patents

Ye-Lin Leu holds a patent for proactive antitumor compounds. The patent features a unique formula that includes various components such as COOZ, where Z can be hydrogen or an alkali metal, and other substituents that enhance the compound's efficacy. This invention represents a significant advancement in the search for effective cancer therapies.

Career Highlights

Throughout her career, Ye-Lin Leu has focused on research and development in the pharmaceutical industry. Her dedication to innovation has led to the creation of valuable compounds that address critical health challenges. With her expertise, she continues to contribute to advancements in medical science.

Collaborations

Ye-Lin Leu has collaborated with esteemed colleagues, including Steve Roffler and Ji-Wang Chern. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Ye-Lin Leu's work in developing proactive antitumor compounds showcases her commitment to innovation in the pharmaceutical field. Her contributions are paving the way for new treatments that could significantly benefit cancer patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…